Di Li

Institution
National Astronomical Observatories of the Chinese Academy of Sciences

Country
China

Field
Aerospace & Astronomy

Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.

 

(Photo: The Paper)

AWARDS
  • Marcel Grossmann Award

Related articles

Potential Target For TGF-β-Driven Cancers Found

The finding that USP15 enhances the stability of TGF-β signaling suggests that targeting USP15 could help treat cancers with TGF-β hyperactivation.

Takeda Receives US$38 Million Polio Eradication Grant From Gates Foundation

With this funding, Takeda will develop, license and supply at least 50 million doses of a polio vaccine per year to more than 70 developing countries.

Mass Vaccination Could Curb HFMD In China

China reported nine million cases of highly infectious HFMD between 2008 and 2013; broad vaccination could help bring these numbers down.

Freaky Fungi Friday

Much more than just mushrooms, fungi—and the people who study them—are simply fascinating.

Promising Dengue Vaccine Faces Final Test

The TV003 vaccine, which researchers believe will protect against all four strains of dengue, is set to complete a phase III trial by 2018.

Anti-Rabies Alliance To Vaccinate Dogs In At-Risk Areas

Mass dog vaccination is now seen as the most cost-effective means to control rabies, which kills roughly 70,000 people every year.

Transmission-Blocking Malaria Vaccine Gets Funding Boost

This malaria vaccine candidate is given to humans but targets mosquitoes, and clinical trials may commence in as little as four years.

Growing Calls For Academia Sinica’s President Wong Chi-Huey To Resign

Taiwan's Legislative Yuan has called for the resignation of Academia Sinica's President Wong Chi-Huey over his daughter's sale of shares in OBI Pharma, a Taiwanese biotech company.

Vaccine Less Effective Against Re-Emerging Japanese Encephalitis Strain

With the re-emergence of a previously rare strain of Japanese encephalitis that is not well covered by the current vaccine, we are on the cusp of a potential infectious disease crisis in Asia.